| Actym Therapeutics |
CA - Berkeley |
Microbial-based immunotherapy platform |
| Biocodex |
France - Gentilly |
Microbiota Treatments |
| BiomeBank |
Australia - Adelaide |
Curated Gut Microbiomes for Disease Treatment |
| BiomX |
Israel - Ness Ziona |
Microbiome-based Therapeutics |
| CHAIN Biotech |
UK - Nottingham |
Microbiome therapeutics |
| ClostraBio |
IL - Chicago |
Food Allergy Treatments |
| CNCure Biotech |
Korea - Hwasun-gun |
Bacterial Platform for Developing Treatments, Radiotheranostics |
| Concerto Biosciences |
MA - Cambridge |
Bacterial Skin Therapies |
 |
India - Hyderabad |
Curia (formerly AMRI) is a CRO/CDMO providing discovery, development, drug substance and drug product manufacturing for small molecules and biologics across 20 global sites. |
| |
Spain - León |
Curia (formerly AMRI) is a CRO/CDMO providing discovery, development, drug substance and drug product manufacturing for small molecules and biologics across 20 global sites. |
| DermBiont |
MA - Boston |
Topical Bacterial Products |
| Eligo Bioscience |
France - Paris |
Protein-based nanodelivery vectors, bacteriophages |
| EnteroBiotix |
UK - Lanarkshire |
Fecal microbiota transplantation |
| Enterome |
France - Evry |
Microbiome-related diseases, diagnostics |
| Enterome |
France - Paris |
Microbiome-related diseases, diagnostics |
| Esperion Therapeutics (2) |
MI - Ann Arbor |
Bacteriome |
| ExeGi Pharma |
MD - Rockville |
Live Therapeutics |
| Finch Therapeutics |
MA - Boston |
Microbiological Therapy |
| Genome & Company |
Korea - Suwon |
Microbiome, Antibody Therapies |
| GI Innovation |
Korea - Seoul |
Microbiome combination drug development |
| Infant Bacterial Therapeutics |
Sweden - Stockholm |
Premature Infant Treatments |
| Juno Bio |
CA - San Francisco |
Vaginal Microbiome Health |
| Kanvas Biosciences |
NJ - Monmouth Junction |
Microbiome Drug Discovery |
| Kobiolabs |
Korea - Seongnam |
Microbiome Therapeutics |
| Liveome |
Korea - Suwon |
Microbiome Therapeutics for Intractable Diseases |
| Locus Biosciences |
NC - Morrisville |
CRISP-engineered Bacteriophage Therapeutics |
| Lxbio Pharmaceuticals |
Portugal - Lisbon |
Bacteriophages, Antibody Fragment, Topical |
| MaaT Pharma |
France - Lyon |
Microbiome Correction |
| MarvelBiome |
MA - Woburn |
Microbial Therapeutics |
| Metagenomi |
CA - Emeryville |
Gene-Edited Microbial Treatments |
| Microba Life Sciences |
Australia - Brisbane |
Metagenomics Platform for Bacteriome Drug Discovery |
| Microbiome Insights |
BC - Richmond |
Microbiome Analysis and Research |
| Microbiotica |
UK - Cambridge |
Gut Bacteria Phenotype to Biomarker/Therapeutics |
| Microviable Therapeutics |
Spain - Gijon |
Intestinal Microbiota Isolation Kit |
| MRM Health |
Belgium - Ghent |
Microbiotic Therapies |
| MyBiotics |
Israel - Rehovot |
Bacterial Products |
| Nubiyota |
ON - Guelph |
Microbiome therapeutics platform |
| OM Pharma |
Switzerland - Meyrin |
Microbial derived immunotherapeutic products |
| Pragma Bio |
CA - San Francisco |
Microbial-derived small molecules |
| Pulmobiotics |
Spain - Barcelona |
Live Biotherapeutics |
| Realize Therapeutics |
IL - Lake Bluff |
Cannabinoid-based & Microbiotic Therapeutics |
| ResVita Bio |
CA - Berkeley |
Engineered Skin Probiotics |
| S-biomedic |
Belgium - Ghent |
Proprietary skin microbiome modulation tech |
| Seres Therapeutics |
MA - Cambridge |
Microbial drugs to counteract antibiotic side effects |
| Siolta Therapeutics |
CA - San Carlos |
Gut Microbiome Modification |
| SNIPR BIOME |
Denmark - Copenhagen |
CRISPR for microbiome management, genetically-modified bacteriophages |
| Telum Therapeutics |
Spain - Noáin |
Bacteriophages |
| Vedanta Biosciences |
MA - Cambridge |
Therapies that modulate pathways of interaction between the human microbiome and the host immune system |
